Clinical Trials Browser

Completed × INDUSTRY × Multiple Sclerosis × Clear all

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT06136923 2024-05-13

An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Phase NA Completed

194 enrolled

BreastThoracic

Breast Neoplasms, Lung Neoplasms, Multiple Sclerosis

NCT02486640 2023-07-24

BETAPREDICT

Completed

162 enrolled

Carcinoma in Situ, Multiple Sclerosis

NCT05438147 2023-04-26

Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms

Phase NA Completed

114 enrolled

Multiple Sclerosis, Neoplasms, Cognitive Dysfunction

NCT02073474 2022-12-20

An Observational Post-Marketing Safety Registry of Sativex®

Completed

978 enrolled

Marijuana Abuse, Diabetes Mellitus, Multiple Sclerosis, Neoplasms, Neuralgia

NCT03134573 2019-03-26

PROmyBETAapp

Completed

96 enrolled

Carcinoma in Situ, Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting

NCT03138421 2019-01-25

Central Pain Study for ABX-1431

Phase 1 Completed

9 enrolled

Multiple Sclerosis, Myelitis, Transverse, Neuromyelitis Optica

Clinical Trials

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

BETAPREDICT

Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms

An Observational Post-Marketing Safety Registry of Sativex®

PROmyBETAapp

Central Pain Study for ABX-1431